Rhythm Pharmaceuticals, Inc. (RYTM)

108.11 -4.42 (-3.93%) USD  |  NASDAQ  |  Aug 28, 12:58
More

Rhythm Pharmaceuticals EPS Diluted (TTM) : -3.118 for June 30, 2026

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -3.118
March 31, 2026 -3.138
December 31, 2025 -3.109
September 30, 2025 -3.103
June 30, 2025 -3.018
March 31, 2025 -2.815
December 31, 2024 -4.360
September 30, 2024 -4.338
June 30, 2024 -4.367
March 31, 2024 -4.638
December 31, 2023 -3.207
September 30, 2023 -3.259
June 30, 2023 -3.291
March 31, 2023 -3.363
December 31, 2022 -3.491
September 30, 2022 -3.589
June 30, 2022 -3.493
March 31, 2022 -3.305
December 31, 2021 -1.354
September 30, 2021 -1.291
June 30, 2021 -1.358
March 31, 2021 -1.359
December 31, 2020 -3.036
September 30, 2020 -3.028
June 30, 2020 -3.304
Date Value
March 31, 2020 -3.841
December 31, 2019 -3.907
September 30, 2019 -3.868
June 30, 2019 -3.342
March 31, 2019 -2.615
December 31, 2018 -2.376
September 30, 2018 -2.045
June 30, 2018 -3.309
March 31, 2018 -3.579
December 31, 2017 -3.253
September 30, 2017 -3.106
June 30, 2017 -1.567
March 31, 2017 -1.010
September 30, 2016 -0.981
June 30, 2016 -0.8441
March 31, 2016 -0.6316
December 31, 2015 -0.4128
September 30, 2015 -0.1959
December 31, 2014 -0.1017
September 30, 2014 -0.1228
June 30, 2014 -0.1502
March 31, 2014 -0.1182
June 30, 2013 -0.0857
March 31, 2013 -0.0365

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.220
Aprea Therapeutics, Inc. -1.077
Alnylam Pharmaceuticals, Inc. 5.923
Anika Therapeutics, Inc. -0.2741
Savara, Inc. -0.5766